CHIRURGIE CARDIOTHORACIQUE ET VASCULAIRE
Gestion et optimisation de l’hémostase
Malagasy
Gestion et optimisation de l’hémostase
/assets/ct/a5f5be13b3/images/syn_placeholder_sqr.png

Chirurgie cardiothoracique et vasculaire

Gestion et optimisation de l’hémostase

Antifibrinolytiques

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation. (manokatra rohy)

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

Loharanon-kevitra‎: Heart Lung Circ 2012;21(11):706-10.

Rakitra‎: PubMed 22842057

DOI‎: 10.1016/j.hlc.2012.06.016

https://www.ncbi.nlm.nih.gov/pubmed/22842057 (manokatra rohy)

Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. (manokatra rohy)

Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L.

Loharanon-kevitra‎: J Cardiothorac Surg 2009;4:25.

Rakitra‎: PubMed 19538741

DOI‎: 10.1186/1749-8090-4-25

https://www.ncbi.nlm.nih.gov/pubmed/19538741 (manokatra rohy)

Current status of pharmacologic therapies in patient blood management. (manokatra rohy)

Goodnough LT, Shander A.

Loharanon-kevitra‎: Anesth Analg 2013;116(1):15-34.

Rakitra‎: PubMed 23223098

DOI‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098 (manokatra rohy)

The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. (manokatra rohy)

Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.

Loharanon-kevitra‎: Anesth Analg 2009;109(1):15-24.

Rakitra‎: PubMed 19535691

DOI‎: 10.1213/ane.0b013e3181a40b5d

https://www.ncbi.nlm.nih.gov/pubmed/19535691 (manokatra rohy)

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. (manokatra rohy)

Howell N, Senanayake E, Freemantle N, Pagano D.

Loharanon-kevitra‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

Rakitra‎: PubMed 22889481

DOI‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 (manokatra rohy)

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. (manokatra rohy)

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.

Loharanon-kevitra‎: Anesth Analg 2010;110(1):21-9.

Rakitra‎: PubMed 19910626

DOI‎: 10.1213/ANE.0b013e3181c0ea6d

https://www.ncbi.nlm.nih.gov/pubmed/19910626 (manokatra rohy)

Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion. (manokatra rohy)

Mansouri M, Attary M, Bagheri K, Massoumi G, Ghavami B.

Loharanon-kevitra‎: Interact Cardiovasc Thorac Surg 2012;15(1):23-7.

Rakitra‎: PubMed 22514257

DOI‎: 10.1093/icvts/ivs114

https://www.ncbi.nlm.nih.gov/pubmed/22514257 (manokatra rohy)

A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. (manokatra rohy)

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, Angelini GD.

Loharanon-kevitra‎: J Thorac Cardiovasc Surg 2006;132(3):475-80, 480.e1-8.

Rakitra‎: PubMed 16935098

DOI‎: 10.1016/j.jtcvs.2006.01.064

https://www.ncbi.nlm.nih.gov/pubmed/16935098 (manokatra rohy)

Tranexamic acid in patients undergoing coronary-artery surgery. (manokatra rohy)

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Loharanon-kevitra‎: N Engl J Med 2017;376(2):136-48.

Rakitra‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (manokatra rohy)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (manokatra rohy)

Nurözler F, Kutlu T, Küçük G.

Loharanon-kevitra‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Rakitra‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (manokatra rohy)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (manokatra rohy)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Loharanon-kevitra‎: JAMA Surg 2013;148(6):538-47.

Rakitra‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (manokatra rohy)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (manokatra rohy)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Loharanon-kevitra‎: JAMA. 2022;328(4):336-47.

Rakitra‎: PubMed 35881121

DOI‎:  10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (manokatra rohy)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (manokatra rohy)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Loharanon-kevitra‎: Anesth Analg 2012;115(2):239-43.

Rakitra‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (manokatra rohy)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (manokatra rohy)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Loharanon-kevitra‎: Ann Thorac Surg 2010;89(5):1489-95.

Rakitra‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (manokatra rohy)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (manokatra rohy)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Loharanon-kevitra‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Rakitra‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (manokatra rohy)

Facteur VII activé recombinant (rFVIIa)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (manokatra rohy)

Ballen J, Raabe M, Muirhead B.

Loharanon-kevitra‎: Can J Anaesth 2006;53(4):353-6.

Rakitra‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (manokatra rohy)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (manokatra rohy)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Loharanon-kevitra‎: Transfusion 2013;53(4):798-804.

Rakitra‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (manokatra rohy)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (manokatra rohy)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Loharanon-kevitra‎: Ann Thorac Surg 2008;85(3):836-44.

Rakitra‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (manokatra rohy)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (manokatra rohy)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Loharanon-kevitra‎: Can J Cardiol 2011;27(6):869.e7-8.

Rakitra‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (manokatra rohy)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (manokatra rohy)

Flynn BC, Steiner ME, Mazzeffi M

Loharanon-kevitra‎: Anesthesiology. 2023 1;139(2):197-210.

Rakitra‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (manokatra rohy)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (manokatra rohy)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Loharanon-kevitra‎: Circulation 2009;120(1):21-7.

Rakitra‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (manokatra rohy)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (manokatra rohy)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Loharanon-kevitra‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Rakitra‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (manokatra rohy)

Off-label use of recombinant human factor VIIa. (manokatra rohy)

Goodnough LT, Levy JH.

Loharanon-kevitra‎: Ann Thorac Surg 2014;98(2):393-5.

Rakitra‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (manokatra rohy)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (manokatra rohy)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Loharanon-kevitra‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Rakitra‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (manokatra rohy)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (manokatra rohy)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Loharanon-kevitra‎: Circulation 2008;118(4):331-8.

Rakitra‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (manokatra rohy)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (manokatra rohy)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Loharanon-kevitra‎: J Vasc Surg 2011;53(4):1032-7.

Rakitra‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (manokatra rohy)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (manokatra rohy)

Lehr EJ, Alford TJ, Wang SH.

Loharanon-kevitra‎: Heart Surg Forum 2010;13(5):E275-9.

Rakitra‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (manokatra rohy)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (manokatra rohy)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Loharanon-kevitra‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Rakitra‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (manokatra rohy)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (manokatra rohy)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Loharanon-kevitra‎: Drugs R D 2015;15(2):187-94.

Rakitra‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (manokatra rohy)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (manokatra rohy)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Loharanon-kevitra‎: A A Case Rep 2015;5(1):3-5.

Rakitra‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (manokatra rohy)

Recombinant activated factor VII in cardiac surgery: a systematic review. (manokatra rohy)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Loharanon-kevitra‎: Ann Thorac Surg 2007;83(2):707-14.

Rakitra‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (manokatra rohy)

Concentrés de facteurs de coagulation

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (manokatra rohy)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Loharanon-kevitra‎: Transfusion 2014;54(5):1348-57.

Rakitra‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (manokatra rohy)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (manokatra rohy)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Loharanon-kevitra‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Rakitra‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (manokatra rohy)

Reducing blood transfusion in aortic surgery: a novel approach. (manokatra rohy)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Loharanon-kevitra‎: Ann Thorac Surg 2019;108(5):1369-75.

Rakitra‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (manokatra rohy)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (manokatra rohy)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Loharanon-kevitra‎: Ann Thorac Surg 2009;88(5):1666-8.

Rakitra‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (manokatra rohy)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (manokatra rohy)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Loharanon-kevitra‎: Crit Care 2016;20:5.

Rakitra‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (manokatra rohy)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (manokatra rohy)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Loharanon-kevitra‎: A A Case Rep 2015;4(10):140-2.

Rakitra‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (manokatra rohy)

State of the art - how I manage coagulopathy in cardiac surgery patients. (manokatra rohy)

Davidson S.

Loharanon-kevitra‎: Br J Haematol 2014;164(6):779-89.

Rakitra‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (manokatra rohy)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (manokatra rohy)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Loharanon-kevitra‎: Anesthesiology 2011;115(6):1179-91.

Rakitra‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (manokatra rohy)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (manokatra rohy)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Loharanon-kevitra‎: JAMA Netw Open 2021;4(4):e213936.

Rakitra‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (manokatra rohy)

Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery: the FARES-II multicenter randomized clinical trial. (manokatra rohy)

Karkouti K, Callum JL, Bartoszko J, Tanaka KA, Knaub S, Brar S, Ghadimi K, Rochon A, Mullane D, Couture EJ, Lin Y, Harle C, Zeller M, Tran DTT, Solomon C, Rao V, Law M, Butt AL, Chen EP, Martins MR, Saha T, Shih AW, Vézina MC, Moussa F, Pereira Cezar Zamper R, Syed S, Buyukdere H, Werner S, Grewal D, Wong D, Vandyck KB, Tanzola R, Hughes B, Royer O, Wong S, Levy JH; FARES-II Study Group

Loharanon-kevitra‎: JAMA 2025;333(20):1781-92.

Rakitra‎: PubMed 40156829

DOI‎: 10.1001/jama.2025.3501

https://pubmed.ncbi.nlm.nih.gov/40156829/ (manokatra rohy)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (manokatra rohy)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Loharanon-kevitra‎: Thromb Haemost 2009;102(1):137-44.

Rakitra‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (manokatra rohy)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (manokatra rohy)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Loharanon-kevitra‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Rakitra‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (manokatra rohy)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (manokatra rohy)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Loharanon-kevitra‎: Anesthesiology 2013;118(1):40-50.

Rakitra‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (manokatra rohy)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (manokatra rohy)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Loharanon-kevitra‎: J Am Heart Assoc 2015;4(6):e002066.

Rakitra‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (manokatra rohy)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (manokatra rohy)

Ranucci M, Baryshnikova E.

Loharanon-kevitra‎: Br J Anaesth 2016;116(5):618-23.

Rakitra‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (manokatra rohy)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (manokatra rohy)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Loharanon-kevitra‎: Can J Anaesth 2012;59(3):299-303.

Rakitra‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (manokatra rohy)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (manokatra rohy)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Loharanon-kevitra‎: Ann Thorac Surg 2019;107(4):1275-83.

Rakitra‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (manokatra rohy)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (manokatra rohy)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Loharanon-kevitra‎: Anesth Analg 2007;104(4):763-5.

Rakitra‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (manokatra rohy)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (manokatra rohy)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Loharanon-kevitra‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Rakitra‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (manokatra rohy)

Desmopressine

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (manokatra rohy)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Loharanon-kevitra‎: Anaesthesia 2010;65(7):688-91.

Rakitra‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (manokatra rohy)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (manokatra rohy)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Loharanon-kevitra‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Rakitra‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (manokatra rohy)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (manokatra rohy)

Wademan BH, Galvin SD.

Loharanon-kevitra‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Rakitra‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (manokatra rohy)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (manokatra rohy)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Loharanon-kevitra‎: Anesth Analg 2010;110(3):702-7.

Rakitra‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (manokatra rohy)

Agents hémostatiques topiques

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (manokatra rohy)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Loharanon-kevitra‎: Ann Surg 2010;251(2):217-28.

Rakitra‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (manokatra rohy)

A review of topical hemostatic agents for use in cardiac surgery. (manokatra rohy)

Barnard J, Millner R.

Loharanon-kevitra‎: Ann Thorac Surg 2009;88(4):1377-83.

Rakitra‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (manokatra rohy)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (manokatra rohy)

Forcillo J, Perrault LP.

Loharanon-kevitra‎: Transfus Apher Sci 2014;50(1):26-31.

Rakitra‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (manokatra rohy)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (manokatra rohy)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Loharanon-kevitra‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Rakitra‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (manokatra rohy)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (manokatra rohy)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Loharanon-kevitra‎: Innovations (Phila) 2012;7(4):229-41.

Rakitra‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (manokatra rohy)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (manokatra rohy)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Loharanon-kevitra‎: J Card Surg 2009;24(6):722-4.

Rakitra‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (manokatra rohy)

Topical haemostatic agents. (manokatra rohy)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Loharanon-kevitra‎: Br J Surg 2008;95(10):1197-225.

Rakitra‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (manokatra rohy)

Tests viscoélastiques pour distinguer une hémorragie chirurgicale d'une coagulopathie

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (manokatra rohy)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Loharanon-kevitra‎: Transfus Med 2006;16(1):31-9.

Rakitra‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (manokatra rohy)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (manokatra rohy)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Loharanon-kevitra‎: Anesthesiology 2011;115(6):1179-91.

Rakitra‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (manokatra rohy)

Management of hemorrhage in cardiothoracic surgery. (manokatra rohy)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Loharanon-kevitra‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Rakitra‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (manokatra rohy)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (manokatra rohy)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Loharanon-kevitra‎: Anesthesiology 2012;117(3):531-47.

Rakitra‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (manokatra rohy)